EMA ADMITS ERROR OVER SOME HUMIRA TRIAL DATA REDACTIONS
February 8th, 2015
THE EUROPEAN Medicines Agency (EMA) has admitted it erred in redacting some clinical trials documentation requested in an information request about Crohn’s disease medicine Humira, manufactured by AbbVie. This followed a legal settlement between EMA and the pharmaco, where the European Union (EU) agency agreed to release only parts of its trial data on the medicine. Following a European Ombudsman probe into the case, where the watchdog concluded it had concerns about the legality of EMA’s actions the agency has now released a reply, where it accepted it ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.